Corticotropin-Releasing Hormone Receptor Antagonists: Framework Design and Synthesis Guided by Ligand Conformational Studies
| Autor: | Paul Krenitsky, Strucely P, Robert Scott Cheeseman, Hodge Carl Nicholas, Thomas E. Christos, Zelda R. Wasserman, Paul J. Gilligan, Ciganek E, Nemeth Ga, Fernandez Ch, Everett Latham Scholfield, Argyrios G. Arvanitis, Aldrich Pe, Robert J. Chorvat |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Models
Molecular Magnetic Resonance Spectroscopy Pyridines Chemistry Stereochemistry Molecular Conformation Corticotropin-releasing hormone receptor Nuclear magnetic resonance spectroscopy Crystallography X-Ray Ligands Ligand (biochemistry) Receptors Corticotropin-Releasing Hormone Solutions Structure-Activity Relationship Pyrimidines Drug Design Drug Discovery Molecular Medicine Receptor |
| Zdroj: | Journal of Medicinal Chemistry. 42:819-832 |
| ISSN: | 1520-4804 0022-2623 |
| Popis: | As described in the preceding paper (Arvanitis et al. J. Med. Chem. 1999, 42), anilinopyrimidines I were identified as potent antagonists of corticotropin-releasing hormone-1 receptor (CRH1-R, also referred to as corticotropin-releasing factor, CRF1-R). Our next goal was to understand the receptor-bound conformation of the antagonists and to use this information to help guide preclinical optimization of the series and to develop new leads. Since receptor structural information was not available, we assumed that these small, high-affinity antagonists would tend to bind in conformations at or energetically close to their global minima and that rigid analogues that maintained the important stereoelectronic features of the bound anilinopyrimidine would also bind tightly. Conformational preferences and barriers to rotation of the anilinopyrimidines were determined by semiempirical methods, and X-ray and variable-temperature NMR spectroscopy provided experimental results that correlated well with calculated structures. Using these data, a key dihedral angle was constrained to design fused-ring analogues, substituted N-arylpyrrolopyridines II, synthesis of which provided CRH1 receptor antagonists with potency equal to that of the initial congeneric leads (Ki = 1 nM) and which closely matched the conformation held by the original compound, as determined by crystallography. In addition to providing a useful template for further analogue synthesis, the study unequivocally determined the active conformation of the anilinopyrimidines. Theoretical and spectroscopic studies, synthesis, and receptor binding data are presented. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|